@article{e51191ea992f44eaad2df759b2155062,
title = "RNA bisulfite sequencing reveals NSUN2-mediated suppression of epithelial differentiation in pancreatic cancer",
abstract = "Abstract: Posttranscriptional modifications in RNA have been considered to contribute to disease pathogenesis and tumor progression. NOL1/NOP2/Sun domain family member 2 (NSUN2) is an RNA methyltransferase that promotes tumor progression in several cancers. Pancreatic cancer relapse inevitably occurs even in cases where primary tumors have been successfully treated. Associations of cancer progression due to reprogramming of the cancer methyl-metabolome and the cancer genome have been noted, but the effect of base modifications, namely 5-methylcytosine (m5C), in the transcriptome remains unclear. Aberrant regulation of 5-methylcytosine turnover in cancer may affect posttranscriptional modifications in coding and noncoding RNAs in disease pathogenesis. Mutations in NSUN2 have been reported as drivers of neurodevelopmental disorders in mice, and upregulated expression of NSUN2 in tumors of the breast, bladder, and pancreas has been reported. In this study, we conducted mRNA whole transcriptomic bisulfite sequencing to categorize NSUN2 target sites in the mRNA of human pancreatic cancer cells. We identified a total of 2829 frequent m5C sites in mRNA from pancreatic cancer cells. A total of 90.9% (2572/2829) of these m5C sites were mapped to annotated genes in autosomes and sex chromosomes X and Y. Immunohistochemistry staining confirmed that the NSUN2 expression was significantly upregulated in cancer lesions in the LSL-KrasG12D/+;Trp53fl/fl;Pdx1-Cre (KPC) spontaneous pancreatic cancer mouse model induced by Pdx1-driven Cre/lox system expressing mutant KrasG12D and p53 deletion. The in vitro phenotypic analysis of NSUN2 knockdown showed mild effects on pancreatic cancer cell 2D/3D growth, morphology and gemcitabine sensitivity in the early phase of tumorigenesis, but cumulative changes after multiple cell doubling passages over time were required for these mutations to accumulate. Syngeneic transplantation of NSUN2-knockdown KPC cells via subcutaneous injection showed decreased stromal fibrosis and restored differentiation of ductal epithelium in vivo. Significance: Transcriptome-wide mRNA bisulfite sequencing identified candidate m5C sites of mRNAs in human pancreatic cancer cells.NSUN2-mediated m5C mRNA metabolism was observed in a mouse model of pancreatic cancer.NSUN2 regulates cancer progression and epithelial differentiation via mRNA methylation.",
author = "Chen, {Szu Ying} and Chen, {Kuan Lin} and Ding, {Li Yun} and Yu, {Chien Hung} and Wu, {Hsin Yi} and Chou, {Ya Yi} and Chang, {Chia Jung} and Chang, {Chih Han} and Wu, {Ya Na} and Wu, {Shang Rung} and Hou, {Ya Chin} and Lee, {Chung Ta} and Chen, {Peng Chieh} and Shan, {Yan Shen} and Huang, {Po Hsien}",
note = "Funding Information: The authors acknowledge technical services from core facilities: Research Center of Clinical Medicine, Center of Cell Therapy, and the Human Biobank and the Cancer Data Bank of National Cheng Kung University Hospital. The authors thank the Core Research Laboratory and the Laboratory Animal Center, College of Medicine, National Cheng Kung University; and Taiwan Animal Consortium. We thank the technical services provided by the following National Core Facilities: Bioimaging Core Facility; and the International Institute for Macromolecular Analysis and Nanomedicine Innovations, National Core Facility for Biopharmaceuticals, Ministry of Science and Technology, Taiwan. Sequencing run, computational analyses and data mining were performed using the system provided by the Center for Bioinformatics and Digital Health at the National Cheng Kung University, supported by Ministry of Science and Technology, Taiwan. The authors acknowledge the mass spectrometry technical research services from NTU Consortia of Key Technologies and NTU Instrumentation Center. We thank the National RNAi Core Facility at Academia Sinica in Taiwan for providing shRNA reagents and related services. This work is supported by grant support from the MOST (110-2320-B-006-038- and 110-2314-B-006-107-) to PHH. Funding Information: The authors acknowledge technical services from core facilities: Research Center of Clinical Medicine, Center of Cell Therapy, and the Human Biobank and the Cancer Data Bank of National Cheng Kung University Hospital. The authors thank the Core Research Laboratory and the Laboratory Animal Center, College of Medicine, National Cheng Kung University; and Taiwan Animal Consortium. We thank the technical services provided by the following National Core Facilities: Bioimaging Core Facility; and the International Institute for Macromolecular Analysis and Nanomedicine Innovations, National Core Facility for Biopharmaceuticals, Ministry of Science and Technology, Taiwan. Sequencing run, computational analyses and data mining were performed using the system provided by the Center for Bioinformatics and Digital Health at the National Cheng Kung University, supported by Ministry of Science and Technology, Taiwan. The authors acknowledge the mass spectrometry technical research services from NTU Consortia of Key Technologies and NTU Instrumentation Center. We thank the National RNAi Core Facility at Academia Sinica in Taiwan for providing shRNA reagents and related services. This work is supported by grant support from the MOST (110-2320-B-006-038- and 110-2314-B-006-107-) to PHH. Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive licence to Springer Nature Limited.",
year = "2022",
month = may,
day = "27",
doi = "10.1038/s41388-022-02325-7",
language = "English",
volume = "41",
pages = "3162--3176",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "22",
}